Bio-Rad Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	529.8	488.1	403.8	434.22	470.78
Short-Term Investments	1,011	1,176	1,203	1,356	399.14
Cash & Short-Term Investments	1,541	1,665	1,607	1,791	869.92
Cash Growth	-7.44%	3.57%	-10.25%	105.84%	-12.23%
Accounts Receivable	460.6	452.5	489	494.65	423.54
Other Receivables	11.9	13.1	11.9	11.6	2.2
Receivables	472.5	465.6	500.9	506.25	425.74
Inventory	740.7	760	780.5	719.32	572.24
Prepaid Expenses	136.5	122.6	140	124.18	109.14
Restricted Cash	2	1.4	0.2	0.01	0.01
Other Current Assets	13.8	16.2	19.6	17.55	13.44
Total Current Assets	2,906	3,030	3,048	3,158	1,990
Property, Plant & Equipment	709.9	688.6	723.7	679.56	716.44
Long-Term Investments	6,103	4,838	7,697	8,830	14,386
Goodwill	579.8	410.5	413.6	406.49	347.34
Other Intangible Assets	174.3	293.6	320.5	332.15	253.94
Other Long-Term Assets	103.8	103.5	96.4	95.8	105.49
Total Assets	10,577	9,364	12,299	13,502	17,799
Accounts Payable	129	122.3	144.6	135.04	141.94
Accrued Expenses	172.3	124.2	139.9	194.79	312.97
Current Portion of Long-Term Debt	0.8	0.8	-	-	-
Current Portion of Leases	36.6	42.1	40.9	36.8	36.92
Current Income Taxes Payable	36.6	31.2	35.8	32.43	10.32
Current Unearned Revenue	48.9	47.8	-	-	50.85
Other Current Liabilities	92.8	99.4	161.6	169.65	127.94
Total Current Liabilities	517	467.8	522.8	568.71	680.94
Long-Term Debt	1,193	1,191	1,190	1,188	0
Long-Term Leases	154.4	140.6	175.1	163.73	186.45
Long-Term Unearned Revenue	14	13.7	-	-	-
Pension & Post-Retirement Benefits	49.2	56.9	59.5	45.3	73.8
Long-Term Deferred Tax Liabilities	1,059	818	1,476	1,770	3,065
Other Long-Term Liabilities	135.9	106.6	135.5	150.61	108.39
Total Liabilities	3,123	2,795	3,558	3,886	4,114
Common Stock	-	-	-	0	0
Additional Paid-In Capital	476	463.2	449.1	447.45	441.73
Retained Earnings	8,176	7,416	9,261	9,898	13,525
Treasury Stock	-1,010	-772.1	-632.5	-263.59	-106.29
Comprehensive Income & Other	-189.1	-538.2	-336	-466.82	-175.55
Shareholders' Equity	7,454	6,569	8,741	9,615	13,685
Total Liabilities & Equity	10,577	9,364	12,299	13,502	17,799
Total Debt	1,385	1,375	1,406	1,388	223.38
Net Cash (Debt)	155.9	289.8	201.6	402.56	646.54
Net Cash Growth	-46.20%	43.75%	-49.92%	-37.74%	-15.53%
Net Cash Per Share	5.71	10.27	6.90	13.52	21.40
Filing Date Shares Outstanding	26.99	28.01	28.52	29.6	29.93
Total Common Shares Outstanding	26.99	28.01	28.52	29.6	29.93
Working Capital	2,389	2,563	2,526	2,589	1,310
Book Value Per Share	276.16	234.52	306.51	324.89	457.20
Tangible Book Value	6,700	5,865	8,007	8,877	13,084
Tangible Book Value Per Share	248.22	209.39	280.77	299.93	437.12
Land	28.9	27.8	28.4	27.8	27.94
Buildings	449.4	426.3	419.8	393.6	385.8
Machinery	1,323	1,183	1,148	1,087	1,100

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q